Our latest research and evaluations is published regularly in:
- 16 June 2017
Be Medicinewise Week: Medicine misuse can happen to anyone
Find out more about NPS MedicineWise's 7th annual Be Medicinewise Week
- 7 June 2017
Evaluation: GP survey results for Chronic pain program
Has management of chronic pain in general practice changed?
- 6 June 2017
Dose confusion with paracetamol/ibuprofen combinations
Avoid potential confusion about new fixed-dose combinations of paracetamol with ibuprofen.
- 20 April 2017
Quick primer on idarucizumab and NOAC-associated bleeding
What is idarucizumab (Praxbind), and why was it developed? When is idarucizumab prescribed, and when is it not?
- 19 April 2017
Idarucizumab (Praxbind) for dabigatran (Pradaxa) reversal: what you should know
Idarucizumab is an emergency reversal agent for dabigatran. Learn about appropriate follow-up after use of idarucizumab.
- 16 February 2017
GP survey results: where to start with osteoporosis
NPS MedicineWise launched a visiting program for health professionals about osteoporosis in October 2015. Find out what GPs thought of it, and whether it changed their practice.
- Medicinewise News
- 2 February 2017
The value of spirometry in clinical practice
Spirometry measures airflow into and out of the lungs and is used in the diagnosis of COPD and asthma. It is underused in Australian medical practice. Find out more about spirometry.
- 11 November 2016
Antibiotic resistance in Australia: here and now
Antibiotic resistance is a problem right now. Read the latest evidence on antibiotic resistance in Australia and find out what health professionals and patients can do to help.
Contact our media team
If you are a journalist seeking comment on a story or more information on any of our programs or campaigns please contact the NPS MedicineWise media team
on 02 8217 8667.
For urgent media requests outside of office hours, please call 0419 618 365. If your request is not urgent you can also email an enquiry.
Publications & Programs
Australian Prescriber is an independent peer-reviewed journal that provides critical commentary on drugs and therapeutics for health professionals.
Peak stories have included the top 10 most expensive drugs, eradication of Hepatitis C, drug seeking behaviours in people and more.
RADAR provides health professionals with timely information on new drugs, medical tests and changes to listings on the Pharmaceutical Benefits Scheme and Medicare Benefits Schedule.
Peak stories have included warfarin, campaigns urging doctors to seeing health reps, and treating Hepatitis C.